Absynth Biologics Limited
Company profile
DissolvedUnited Kingdom
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2019-08-31
IXBRL · 115 source facts · 11 selected values
Not assessedlegacy record
Accounts to 2019-08-31
IXBRL · 115 source facts · 11 selected values
Not assessed
legacy record
- Reporting period
- 2018-03-01 to 2019-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 39
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0081_06029069_20190831
- Source archive
- Accounts_Monthly_Data-August2020.zip
Accounts to 2018-02-28
IXBRL · 97 source facts · 21 selected values
Not assessedlegacy record
Accounts to 2018-02-28
IXBRL · 97 source facts · 21 selected values
Not assessed
legacy record
- Reporting period
- 2017-08-01 to 2018-02-28
- Extraction status
- Legacy / not assessed
- Numeric facts
- 53
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0060_06029069_20180228
- Source archive
- Accounts_Monthly_Data-November2018.zip
Accounts to 2017-07-31
IXBRL · 109 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2017-07-31
IXBRL · 109 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2016-08-01 to 2017-07-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 65
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0052_06029069_20170731
- Source archive
- Accounts_Monthly_Data-March2018.zip
Registered details
06029069- Status
- Dissolved
- Type
- Unknown
- Incorporated
- —
- Jurisdiction
- —
- Registered office
- —
Classification
0 SIC codesNo SIC classification available.
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsEquipment to Support Prophylactic Antibacterial Vaccine DevelopmentLead
Innovate UK · Centres · 2017-03-01 – 2017-03-31
£47,500
awarded
A novel prophylactic vaccine and delivery platform to prevent Clostridium difficile infectionsLeadInnovate UK · Feasibility Studies · 2016-05-01 – 2017-10-31 · with 1 other participant£69,983awarded
A novel prophylactic vaccine and delivery platform to prevent Clostridium difficile infectionsLead
Innovate UK · Feasibility Studies · 2016-05-01 – 2017-10-31 · with 1 other participant
£69,983
awarded
Absynth Biologics Limitedlead£69,983
Staphylococcus aureus Infections - Development of A Novel, Effective VaccineLeadInnovate UK · Collaborative R&D · 2014-01-01 – 2017-12-31 · with 1 other participant£1,552,975awarded
Staphylococcus aureus Infections - Development of A Novel, Effective VaccineLead
Innovate UK · Collaborative R&D · 2014-01-01 – 2017-12-31 · with 1 other participant
£1,552,975
awarded
Absynth Biologics Limitedlead£1,552,975
Building A Product Pipeline – Establishing The Commercial Potential Of New ProductsLead
Innovate UK · Feasibility Studies · 2013-03-01 – 2014-05-31
£150,000
awarded
Bacterial Vaccines and Therapies - Building a Product PipelineLead
Innovate UK · GRD Proof of Market · 2012-02-01 – 2012-06-30
£25,000
awarded